Contact Us

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Endocrine systems consist of various glands, which release specific hormones into the bloodstream in human body. These hormones are carried with blood throughout the body and control various functions of the body such as metabolism, growth and development, reproduction, stimuli response, and homeostasis. Endocrine system consists of various glands such as hypothalamus, pancreas, adrenal glands, thyroid, and pituitary gland. The hormones secreted by these glands are used to maintain various biological functions in human system. Therefore, imbalance in the concentrations of hormones in human system may lead to certain conditions. Endocrine testing consists of diagnosis of concentration of endocrine hormones in human system such as Estradiol, Testosteron, Progesterone, Insulin, Thyroid, Luteinizing, Cortisol DHEA-S, Prolactin, Follicle stimulating hormone, Human chorionic gonadotropin, and Hormone. The testing helps to understand the concentration of specific hormones in blood.

Figure 1. Global Endocrine Testing Market Value (US$ Mn), 2016-2027

Endocrine Testing  | Coherent Market Insights

The global endocrine testing market size is estimated to be valued at US$ 3,403.0 million in 2020 and is expected to exhibit a CAGR of 5.3 % over the forecast period (2020-2027).

Significant growth of endocrine testing market is mainly due to factors such as increasing prevalence of endocrine related disorders such as thyroid related conditions (hyperthyroidism and hypothyroidism), diabetes, hypogonadism, hypergonadism, and adrenal gland related conditions (hypoadrenocorticism and hypercorticism). According to American Thyroid Association in 2017, 20 million American population is suffering from thyroid related conditions and 60% of the population are unaware about the thyroid related conditions they are suffering from. Moreover, according to diabetes.co.uk, a global diabetes community in 2019, 30 million Indian population is diagnosed with diabetic conditions and 9% of the population belongs to rural areas in India. Imbalance of follicle stimulating hormone can lead to conditions such as infertility and sexual disorders. According to the report of Maternal Health Task Force, in 2017 around 50 million couples suffer from problems such as infertility and sexual disorders.

request-sample

Endocrine Testing Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2019: US$ 3,403.0 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 5.3% 2027 Value Projection: US$ 4,878.1 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC, Israel, and Rest of the Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Test: Thyroid, Insulin, Follicle Stimulating Hormone, Luteinizing, Hormone, Estradiol, Testosterone, Human Chorionic Gonadotropin, Prolactin, Cortisol DHEA-S, Others.
  • By Diagnostic Technology: Immunoassay, Tandem Mass Spectroscopy, Monoclonal and Polyclonal antibodies, Sensors Technologies, Clinical Chemistry, Others.
  • By End User: Hospitals, Diagnostic Laboratories, Others.
Companies covered:

Abbott Laboratories, Thermo Fisher Scientific, Bio-Rad Laboratories, Inc, Beckmann Coulter, Inc, Agilent Technologies, Inc, Siemens Healthineers AG, BioMérieux SA, Quest Diagnostics, and F. Hoffmann-La Roche AG

Growth Drivers:
  • Commercial tie-ups and acquisitions by key players
  • Increasing incidence of endocrine related conditions globally
Restraints & Challenges:
  • Lack of skilled professionals for carrying out testing procedures
  • Liquid chromatography-tandem mass spectrometry requires high cost instrument and highly specialized skilled individuals

Global Endocrine Testing Market- Impact of Coronavirus (Covid-19) Pandemic

There is a bidirectional relationship between COVID-19 and endocrine system disorders. According to report of Journal of Cytology in April 2020, various guidelines such as social distancing, use of personal protection equipment, management of spills of blood while collecting blood during the testing procedures such as fine needle aspiration (FNA) are necessary to avoid COVID-19 infections. Moreover, according to report by Touch Endocrinology, a health professional service in the U.K., in March 2020, the patients should take two abnormal glycemic  tests in case of asymptomatic individuals while diagnosis of diabetes and must be aware of hyperglycaemia in case of symptomatic individual with COVID-19 infections.

Figure 2. Global Endocrine Testing Market Share (%), by Region, 2020

Endocrine Testing  | Coherent Market Insights

Among regions, in North America endocrine testing market, key companies are focusing on strategic mergers and acquisitions to expand the number of testing facilities and advancements in testing procedures, which is expected to drive the market growth in this region. For instance, in September 2020, Empower Clinics announced the acquisition of Kai Medical Laboratory, LLC. Under this agreement, Kai Medical Laboratory offers Empower Clinics with diversified testing facilities in endocrinology, hormone testing, toxicology, and immunology testing.

Moreover, in Europe endocrine testing market, key companies are focusing on strategic partnerships for the development in endocrinology diagnosis procedures, which is expected to drive the global endocrine testing market growth in this region. For instance, in 2019, the European Federation of Ethical and Alternative Banks (FEBEA) and the Fondation de la Maison de la Chimie, a non-profit association, entered into partnership with French Ministry of Ecological and Solidarity Transition and announced launch of PEPPER, a public-private research platform on identification of endocrine disruptors and their associated conditions.

Key Players

Major players operating in the global endocrine testing market include Abbott Laboratories, Thermo Fisher Scientific, Bio-Rad Laboratories, Inc, Beckmann Coulter, Inc, Agilent Technologies, Inc, Siemens Healthineers AG, BioMérieux SA, Quest Diagnostics, and F. Hoffmann-La Roche AG.

Endocrine testing includes diagnosis of endocrine related disorders such as infertility, diabetes, and thyroid related disorders. The diagnosis of various endocrine system disorders are determined by evaluating different endocrine hormone levels in the blood. The global endocrine testing market is expected to witness significant growth, owing to increasing incidence of lifestyle disorders such as hypothyroidism, hyperthyroidism, infertility, and diabetes. For instance, according to American Thyroid Association report 2017, the U.S. performs approximately 15% to 30% thyroid fine needle aspiration (FNA) on an annual basis.

Market Dynamics

Increasing approval of novel testing devices and diagnostic procedures, and increasing outsourcing for technological advancements are major factors driving the endocrine testing market growth. For instance, in 2019, Abbott Laboratories received approval for Afinion HbA1c Dx test from the U.S. Food Drug Administration. Afinion HbA1c Dx test is a quick and rapid test for diagnosis of hemoglobin A1c in just 3 minutes, thus increasing the patient comfort.

Moreover, introduction of new approaches in endocrine hormone testing and implementation of advanced technologies in the global endocrine testing market are expected to boost the market growth. For instance, in 2018, Ortho Clinical Diagnostics launched VITROS C -peptide Assay for the U.S. and countries accepting CE mark. VITRO C-peptide assay follows c-peptide measurement for diagnosis of types of diabetes and associated conditions.

Key features of the study:

  • This report provides in-depth analysis of the global endocrine testing market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020–2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global endocrine testing market based on the following parameters – company overview, financial performance, drugs portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Abbott Laboratories, Thermo Fisher Scientific, Bio-Rad Laboratories, Inc, Beckmann Coulter, Inc, Agilent Technologies, Inc, Siemens Healthineers AG, BioMérieux SA, Quest Diagnostics, and F. Hoffmann-La Roche AG
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future device launches, class up-gradation, market expansion, and marketing tactics
  • The global endocrine testing market report caters to various stakeholders in this industry including investors, suppliers, drugs manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global endocrine testing market

Detailed Segmentation:

  • Global Endocrine Testing Market, By Test :
    • Thyroid
    • Insulin
    • Follicle Stimulating Hormone
    • Luteinizing
    • Hormone
    • Estradiol
    • Testosterone
    • Progesterone
    • Human Chorionic Gonadotropin
    • Prolactin
    • Cortisol DHEA-S
    • Others
  • Global Endocrine Testing Market, By Diagnostic Technology :
    • Immunoassay
    • Tandem Mass Spectroscopy
    • Monoclonal and Polyclonal Antibodies
    • Sensors Technologies
    • Clinical Chemistry
    • Others
  • Global Endocrine Testing Market, By End User :
    •  Hospitals
    • Diagnostic Laboratories
    • Others
  • Global Endocrine Testing Market , By Region:
    • North America
      • By Indication :
        • Thyroid
        • Insulin
        • Follicle Stimulating Hormone
        • Luteinizing
        • Hormone
        • Estradiol
        • Testosterone
        • Progesterone
        • Human Chorionic Gonadotropin
        • Prolactin
        • Cortisol DHEA-S
        • Others
      • By Diagnostic Technology :
        • Immunoassay
        • Tandem Mass Spectroscopy
        • Monoclonal and Polyclonal Antibodies
        • Sensors Technologies
        • Clinical Chemistry
        • Others
      • By End User:
        • Hospitals
        • Diagnostic Laboratories
        • Others
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Indication :
        • Thyroid
        • Insulin
        • Follicle Stimulating Hormone
        • Luteinizing
        • Hormone
        • Estradiol
        • Testosterone
        • Progesterone
        • Human Chorionic Gonadotropin
        • Prolactin
        • Cortisol DHEA-S
        • Others
      • By Diagnostic Technology :
        • Immunoassay
        • Tandem Mass Spectroscopy
        • Monoclonal and Polyclonal Antibodies
        • Sensors Technologies
        • Clinical Chemistry
        • Others
      • By End User:
        • Hospitals
        • Diagnostic Laboratories
        • Others
      • By End User:
        • Hospitals
        • Diagnostic Laboratories
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Indication :
        • Thyroid
        • Insulin
        • Follicle Stimulating Hormone
        • Luteinizing
        • Hormone
        • Estradiol
        • Testosterone
        • Progesterone
        • Human Chorionic Gonadotropin
        • Prolactin
        • Cortisol DHEA-S
        • Others
      • By Diagnostic Technology :
        • Immunoassay
        • Tandem Mass Spectroscopy
        • Monoclonal and Polyclonal Antibodies
        • Sensors Technologies
        • Clinical Chemistry
        • Others
      • By End User:
        • Hospitals
        • Diagnostic Laboratories
        • Others
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Indication :
        • Thyroid
        • Insulin
        • Follicle Stimulating Hormone
        • Luteinizing
        • Hormone
        • Estradiol
        • Testosterone
        • Progesterone
        • Human Chorionic Gonadotropin
        • Prolactin
        • Cortisol DHEA-S
        • Others
      • By Diagnostic Technology :
        • Immunoassay
        • Tandem Mass Spectroscopy
        • Monoclonal and Polyclonal Antibodies
        • Sensors Technologies
        • Clinical Chemistry
        • Others
      • By End User:
        • Hospitals
        • Diagnostic Laboratories
        • Others
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Indication :
        • Thyroid
        • Insulin
        • Follicle Stimulating Hormone
        • Luteinizing
        • Hormone
        • Estradiol
        • Testosterone
        • Progesterone
        • Human Chorionic Gonadotropin
        • Prolactin
        • Cortisol DHEA-S
        • Others
      • By Diagnostic Technology :
        • Immunoassay
        • Tandem Mass Spectroscopy
        • Monoclonal and Polyclonal Antibodies
        • Sensors Technologies
        • Clinical Chemistry
        • Others
      • By End User:
        • Hospitals
        • Diagnostic Laboratories
        • Others
      • By Country/Region:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Indication :
        • Thyroid
        • Insulin
        • Follicle Stimulating Hormone
        • Luteinizing
        • Hormone
        • Estradiol
        • Testosterone
        • Progesterone
        • Human Chorionic Gonadotropin
        • Prolactin
        • Cortisol DHEA-S
        • Others
      • By Diagnostic Technology :
        • Immunoassay
        • Tandem Mass Spectroscopy
        • Monoclonal and Polyclonal Antibodies
        • Sensors Technologies
        • Clinical Chemistry
        • Others
      • By End User:
        • Hospitals
        • Diagnostic Laboratories
        • Others
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Abbott Laboratories.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Thermo Fisher Scientific.
    • Bio-Rad Laboratories, Inc.
    • Beckmann Coulter, Inc.
    • Agilent Technologies
    • Hoffmann-La Roche AG
    • Siemens Healthineers AG.
    • BioMerieux SA
    • Quest Diagnostic.

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Test
      • Market Snippet, By Diagnostic Technology
      • Market Snippet, By End User
      • Market Snippet, By Region
      • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Impact Analysis
    • Market Opportunities
    • New Product Launches
    • Mergers and Acquisitions
    • Regulatory Scenario
    • Pest Analysis
    • Porters Five Forces Model
  4. Global Endocrine Testing Market, Impact of COVID-19 Pandemic
    • Post COVID-19 Impact
    • Implementation diagnosis/testing guidelines
    • Implementation of testing guidelines in case of diabetes diagnosis
  5. Global Endocrine Testing Market, By Indication, 2020-2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
        • Thyroid
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Insulin
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2020–2027, (US$ Mn)
        • Follicle Stimulating Hormone
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2020–2027, (US$ Mn)
        • Luteinizing
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2020–2027, (US$ Mn)
        • Hormone
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2020–2027, (US$ Mn)
        • Estradiol
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2020–2027, (US$ Mn)
        • Testosterone
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2020–2027, (US$ Mn)
        • Progesterone
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2020–2027, (US$ Mn)
        • Human chorionic gonadotropin
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2020–2027, (US$ Mn)
        • Prolactin
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2020–2027, (US$ Mn)
        • Cortisol DHEA-S
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2020–2027, (US$ Mn)
        • Others
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2020–2027, (US$ Mn)
  6. Global Endocrine Testing Market, By Diagnostic Technology, 2020–2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
    • Segment Trends
      • Immunoassay
        • Introduction
        • Market size and forecast, and Y-o-Y Growth, 2020-2027, (US$ Mn)
      • Tandem Mass Spectroscopy
        • Introduction
        • Market Size and Forecast, and Y-o-Y Growth, 2020-2027, (US$ Mn)
      • Monoclonal and Polyclonal antibodies
        • Introduction
        • Market Size and Forecast, and Y-o-Y Growth, 2020-2027, (US$ Mn)
      • Sensors Technologies
        • Introduction
        • Market Size and Forecast, and Y-o-Y Growth, 2020-2027, (US$ Mn)
      • Clinical Chemistry
        • Introduction
        • Market Size and Forecast, and Y-o-Y Growth, 2020-2027, (US$ Mn)
      • Others
        • Introduction
        • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
  7. Global Endocrine Testing Market, By End User, 2020 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017– 2027
      • Segment Trends
        • Hospitals
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
        • Diagnostic Laboratories
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
        • Others
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
  8. Global Endocrine Testing Market, By Region, 2020–2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, By Country, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Countries, 2017–2027
    • North America
      • Introduction
      • Market Size and Forecast, By Test, 2020–2027 (US$ Mn)
      • Market Size and Forecast, By Diagnostic Technology, 2020–2027 (US$ Mn)
      • Market Size and Forecast, By End User, 2020–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2020–2027 (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, By Test, 2020–2027 (US$ Mn)
      • Market Size and Forecast, By Diagnosis Technology, 2020–2027 (US$ Mn)
      • Market Size and Forecast, By End User, 2020–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2020–2027 (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, By Test, 2020–2027 (US$ Mn)
      • Market Size and Forecast, By Diagnosis Technology, 2020–2027 (US$ Mn)
      • Market Size and Forecast, By End User, 2020–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2020–2027 (US$ Mn)
        • Germany
        • U.K.
        • France       
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, By Test, 2020–2027 (US$ Mn)
      • Market Size and Forecast, By Diagnosis Technology, 2020–2027 (US$ Mn)
      • Market Size and Forecast, By End User, 2020–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2020–2027 (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, By Test, 2020–2027 (US$ Mn)
      • Market Size and Forecast, By Diagnostic Technology, 2020–2027 (US$ Mn)
      • Market Size and Forecast, By End User, 2020–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2020–2027 (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, By Test, 2020–2027 (US$ Mn)
      • Market Size and Forecast, By Diagnostic Technology, 2020–2027 (US$ Mn)
      • Market Size and Forecast, By End User, 2020–2027 (US$ Mn)
      • Market Size and Forecast, By Country/Region, 2020–2027 (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  9. Competitive Landscape
    • Company Profiles
      • Abbott Laboratories.*
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Thermo Fisher Scientific.
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Bio-Rad Laboratories, Inc.
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Beckmann Coulter, Inc.
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Agilent Technologies, Inc.
        •  Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Siemens Healthineers AG
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • BioMérieux SA
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Quest Diagnostics
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • F. Hoffmann-La Roche AG
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies

*Browse 45 market data tables and 35 figures on "Global Endocrine Testing Market– Regional forecast to 2027”.

Frequently Asked Questions

The global endocrine testing market size is estimated to be valued at US$ 3,403.0 Mn million in 2020 and is expected to exhibit a CAGR of 5.3 % between 2020 and 2027.
Commercial tie-ups and acquisitions by key players, and increasing prevalence of hyperthyroidism, hypothyroidism, diabetes, hypogonadism, hypergonadism, and adrenal gland related conditions.
Insulin endocrine testing market segment is estimated to hold major endocrine testing market share in 2020, owing to increasing number of diabetes testing procedures.
North America endocrine testing market is estimated to generate largest revenue share in 2020 in the global endocrine testing market.
Lack of clinical skilled professionals during the testing of endocrine testing procedures and adequate developed facilities for testing procedures in low income countries are the major factors hampering the global endocrine testing market growth.
Major players operating in global endocrine testing market include Abbott Laboratories, Thermo Fisher Scientific, Bio-Rad Laboratories, Inc, Beckmann Coulter, Inc, Agilent Technologies, Inc, Siemens Healthineers AG, BioMérieux SA, Quest Diagnostics, and F. Hoffmann-La Roche AG.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner